Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Alcon Inc (NY: ALC )

74.95 +1.42 (+1.93%)
Streaming Delayed Price Updated: 1:42 PM EST, Nov 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 664,169
Open 74.33
Bid (Size) 74.93 (4)
Ask (Size) 74.97 (3)
Prev. Close 73.53
Today's Range 74.32 - 75.17
52wk Range 63.78 - 86.20
Shares Outstanding 489,219,355
Dividend Yield 0.31%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Intel To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
The Latest Analyst Ratings for Alcon
Via Benzinga

Performance

YTD
+8.65%
+8.65%
1 Month
+6.43%
+6.43%
3 Month
-12.03%
-12.03%
6 Month
-4.14%
-4.14%
1 Year
+10.45%
+10.45%

More News

Read More
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Why Medical Device Company Alcon Shares Are Sliding Today
Via Benzinga
Where Alcon Stands With Analysts
Via Benzinga
Alcon Inc. (NYSE: ALC) Highlighted for Surprising Price Action
Via Investor Brand Network
US Stocks On Track To Build On Gains As Traders Await A Batch Of Data; Can Market Resist Profit Taking?
Via Benzinga
Topics Economy
Exposures Interest Rates
Varex Imaging Reports Weak Sales, Joins Alcon, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Alcon Reports Third Quarter 2023 Results
From Alcon Inc. Investors
Via Business Wire
Where Alcon Stands With Analysts
Via Benzinga
Expert Ratings for Alcon
Via Benzinga
Why Lifecore Biomedical Shares Are Skyrocketing Today
Via Benzinga
Alcon Gears Up For Q3 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts
Via Benzinga
Alcon Showcases Cloud-based Planning and World-class Digital Technologies During AAO 2023
From Alcon Inc. Investors
Via Business Wire
Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopia
From Alcon Inc. Investors
Via Business Wire
Cataract Surgery with Alcon’s AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle Dependence
From Alcon Inc. Corporate
Via Business Wire
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030
Via FinancialNewsMedia
Exposures COVID-19
Alcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical Teams
From Alcon Inc. Corporate
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 17, 2023
Via Benzinga
NVIDIA To Rally Around 84%? Here Are 10 Other Analyst Forecasts For Thursday
Via Benzinga
Alcon Reports Second Quarter 2023 Results
From Alcon Inc. Investors
Via Business Wire
US Stocks Set For Bullish Open As Analyst Shrugs Off Seasonal Lull: Here Are Key Data For Investors This Week
Via Benzinga
7 Top Growth Stocks to Watch for H2 2023
Via InvestorPlace
Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer
From Lifecore Biomedical, Inc.
Via GlobeNewswire
Alcon Advances Company’s Social Impact Through Global Volunteerism
From Alcon Inc. Corporate
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.